RECOVAC - Long Term Efficacy and Safety of COVID-19 (SARS-CoV-2) Vaccination in Kidney Disease Patients

NCT04841785 · clinicaltrials.gov ↗
COMPLETED
Status
4868
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

University Medical Center Groningen